Form 4: United Therapeutics Director Judy D. Olian Reports Stock Transactions

Director Judy D. Olian reports the acquisition and disposition of United Therapeutics Corp (UTHR) common stock and stock options on September 17, 2024.

Summary

• On September 17, 2024, Judy D. Olian, a director of United Therapeutics Corp (UTHR), engaged in transactions involving the company's stock.
• Olian acquired 2,300 shares of common stock at a price of $112.14 per share through the exercise of stock options.
• Simultaneously, Olian disposed of 2,300 shares of common stock at a price of $353.22 per share.
• Following these transactions, Olian directly owns 7,405 shares of United Therapeutics Corp.
• Olian also disposed of 2,300 stock options and now owns 2,320 stock options.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about insider trading activity.

Positives

• The exercise of stock options and subsequent sale of shares suggests the director sees value in the company's stock, as they are willing to exercise options and then sell shares at a profit.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may influence investor perception of the company's stock, although the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates